EQUITY (Details Narrative)
₪ / shares in Units, $ / shares in Units, ₪ in Millions |
|
|
|
1 Months Ended |
3 Months Ended |
12 Months Ended |
|
|
Sep. 30, 2025
USD ($)
$ / shares
shares
|
Jul. 31, 2025
$ / shares
shares
|
Jul. 29, 2025
USD ($)
|
Nov. 30, 2024
USD ($)
shares
|
Mar. 31, 2022
USD ($)
$ / shares
shares
|
Mar. 31, 2022
ILS (₪)
₪ / shares
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2024
USD ($)
shares
|
Dec. 31, 2025
₪ / shares
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Sale of stock price per share | (per share) |
|
|
|
|
|
|
$ 3.49
|
|
|
₪ 0.00286
|
| Business acquisition description |
|
|
|
|
the Company completed a financing round through a private placement and a public offering. As part of the public offering,
the Company issued 352,276 units, each composed of 8.74 ordinary shares and 5.68 Series 3 options. The options will vest over a period
of 3 years, with an exercise price of $9.1 (NIS 32) for one year period and $11.4 (NIS 41.2) for additional two-year period. In the private
placement, the Company issued 42,735 units, each composed of 8.74 ordinary shares and 7.43 Series 3 options as well as 16,239 units,
each composed of 8.74 ordinary shares and 5.68 Series 3 options. Gross issue proceeds were $29 million (NIS 96 million). Issuance costs
amounted to USD 1.7 million (NIS 5.7 million), including NIS 0.5 million paid to an advisor through the allocation of shares and Series
3 options, were recognized as a deduction from additional paid-in capital.
|
the Company completed a financing round through a private placement and a public offering. As part of the public offering,
the Company issued 352,276 units, each composed of 8.74 ordinary shares and 5.68 Series 3 options. The options will vest over a period
of 3 years, with an exercise price of $9.1 (NIS 32) for one year period and $11.4 (NIS 41.2) for additional two-year period. In the private
placement, the Company issued 42,735 units, each composed of 8.74 ordinary shares and 7.43 Series 3 options as well as 16,239 units,
each composed of 8.74 ordinary shares and 5.68 Series 3 options. Gross issue proceeds were $29 million (NIS 96 million). Issuance costs
amounted to USD 1.7 million (NIS 5.7 million), including NIS 0.5 million paid to an advisor through the allocation of shares and Series
3 options, were recognized as a deduction from additional paid-in capital.
|
|
|
|
|
| Purchase price per share | $ / shares |
$ 1.00
|
$ 2.00
|
|
|
$ 8.74
|
|
|
|
|
|
| Proceeds from issuance or sale of equity |
|
|
|
|
$ 29,000,000
|
₪ 96.0
|
|
|
|
|
| Payments of debt issuance costs |
|
|
|
|
$ 1,700,000
|
5.7
|
$ 10,875,000
|
|
|
|
| Aggregate purchase price, value |
|
|
|
|
|
₪ 0.5
|
$ 429,000
|
|
$ 100,000
|
|
| Number of warrant issued |
6,022,500
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price | $ / shares |
|
$ 3.06
|
|
|
|
|
$ 11.5
|
|
|
|
| Warrant issuance term |
5 years
|
5 years
|
|
|
|
|
5 years
|
|
|
5 years
|
| Date of issuance |
|
Jul. 31, 2025
|
|
|
|
|
|
|
|
|
| Aggregate amount | $ |
|
|
|
|
|
|
$ 3,870,000
|
|
|
|
| Aggregate offering price | $ |
$ 1,000,000,000.0
|
|
|
|
|
|
|
|
|
|
| Share-Based Payment Arrangement, Tranche One [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price | $ / shares |
$ 1.50
|
|
|
|
|
|
|
|
|
|
| Share-Based Payment Arrangement, Tranche Two [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price | $ / shares |
2.00
|
|
|
|
|
|
|
|
|
|
| Share-Based Payment Arrangement, Tranche Three [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price | $ / shares |
$ 3.00
|
|
|
|
|
|
|
|
|
|
| Chardan Capital Markets LLC [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of warrant issued |
|
350,000
|
|
|
|
|
|
|
|
|
| Standby Equity Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Initial commitment fee | $ |
|
|
|
$ 100,000
|
|
|
|
|
|
|
| Deferred commitment fee | $ |
|
|
|
100,000
|
|
|
|
|
|
|
| Aggregate purchase price, deferred fee | $ |
|
|
|
$ 3,000,000.0
|
|
|
|
|
|
|
| Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Aggregate of sales amount | $ |
|
|
$ 10,950,000
|
|
|
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Aggregate purchase price, value | $ |
|
|
|
|
|
|
|
[1] |
|
|
| Outstanding voting power, percentage |
|
|
|
|
|
|
4.99%
|
|
|
|
| Issued and outstanding voting rights, percentage |
|
|
|
|
|
|
9.99%
|
|
|
|
| Number of pre-funded warrants to sponsor |
133,005,000
|
2,499,364
|
|
|
|
|
394,546
|
|
39,381
|
|
| Number of shares issued |
|
|
|
|
|
|
1,142,820
|
|
|
|
| Aggregate amount | $ |
|
|
|
|
|
|
$ 1,000
|
|
|
|
| Authorized share capital |
1,000,000,000
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Sponsor [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of pre-funded warrants to sponsor |
6,777,706
|
150,000
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Yorkville Advisors Global LP [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Issuance and sale of stock |
|
|
|
|
|
|
394,546
|
|
|
|
| Aggregate of sales amount | $ |
|
|
|
|
|
|
$ 400,000
|
|
|
|
| Weighted average share price | $ / shares |
|
|
|
|
|
|
$ 1.03
|
|
|
|
| Common Stock [Member] | Chardan Capital Markets LLC [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of ordinary shares issued |
5,570,350
|
350,000
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Standby Equity Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Share based compensation purchase price, percentage |
|
|
|
97.00%
|
|
|
|
|
|
|
| Outstanding voting power, percentage |
|
|
|
4.99%
|
|
|
|
|
|
|
| Issued and outstanding voting rights, percentage |
|
|
|
19.99%
|
|
|
|
|
|
|
| Initial commitment shares |
|
|
|
39,381
|
|
|
|
|
|
|
| Common Stock [Member] | Maximum [Member] | Standby Equity Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Aggregate purchase price, value | $ |
|
|
|
$ 12,000,000.0
|
|
|
|
|
|
|
| Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of pre-funded warrants to sponsor |
|
5,000,000
|
|
|
|
|
|
|
|
|
| Warrant [Member] | Sponsor [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of pre-funded warrants to sponsor |
40,360,895
|
|
|
|
|
|
|
|
|
|
| Prefunded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of pre-funded warrants to sponsor |
18,000,000
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price | $ / shares |
$ 0.0001
|
|
|
|
|
|
|
|
|
|
| Prefunded Warrants [Member] | Sponsor [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of pre-funded warrants to sponsor |
5,000,000
|
1,525,926
|
|
|
|
|
|
|
|
|
| Warrant exercise price | $ / shares |
|
$ 0.0001
|
|
|
|
|
|
|
|
|
| Prefunded Warrants [Member] | Chardan Capital Markets LLC [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of warrant issued |
5,000,000
|
|
|
|
|
|
|
|
|
|
| One Year [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Stock option exercise price | (per share) |
|
|
|
|
$ 9.1
|
₪ 32
|
|
|
|
|
| Two Years [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Stock option exercise price | (per share) |
|
|
|
|
$ 11.4
|
₪ 41.2
|
|
|
|
|
| Issue One [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of ordinary shares issued |
|
|
|
|
42,735
|
|
|
|
|
|
| Issue One [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued for services |
|
|
|
|
8.74
|
8.74
|
|
|
|
|
| Issue Two [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of ordinary shares issued |
|
|
|
|
16,239
|
|
|
|
|
|
| Issue Two [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued for services |
|
|
|
|
8.74
|
8.74
|
|
|
|
|
| Series Three [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Purchase price per share | $ / shares |
|
|
|
|
$ 5.68
|
|
|
|
|
|
| Series Three [Member] | Issue One [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued for services |
|
|
|
|
7.43
|
7.43
|
|
|
|
|
| Series Three [Member] | Issue Two [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued for services |
|
|
|
|
5.68
|
5.68
|
|
|
|
|
| Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of ordinary shares issued |
|
|
|
|
352,276
|
|
|
|
|
|
|
|